Clinical Study

A Study Of Ly3303560 In Participants With Early Symptomatic Alzheimer's Disease

Posted Date: Aug 27, 2019

  • Investigator: Lawrence Goldstick
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease.




Alzheimer's Disease

For More Information:

Sarah Hiti

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.